Picture of Spexis AG logo

SPEX Spexis AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Polyphor Gets USD 2.3 Mln Award From Carb-X To Support Development Of New Class Of Antibiotics

Dec 11 (Reuters) - POLYPHOR AG  POLN.S :
    * RECEIVES AN ADDITIONAL USD 2.3 MILLION AWARD FROM CARB-X
TO
SUPPORT ONGOING DEVELOPMENT OF A NEW CLASS OF ANTIBIOTICS
TARGETING MULTI-DRUG RESISTANT GRAM-NEGATIVE PATHOGENS
    * MAY ALSO RECEIVE UP TO USD 13 MILLION IN FUTURE OPTION
STAGES
THAT COULD TAKE PROGRAM THROUGH A FIRST-IN-HUMAN PROGRAM IF
CERTAIN PROJECT MILESTONES ARE MET

Source text for Eikon:  ID:nEQ27MsFta 
Further company coverage:  POLN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Spexis AG

See all news